Weekly Recap: 22nd Century Group, Inc. rally and nicotine cap advocacy

22nd Century Group, Inc. (NASDAQ:XXII) surged after reports the Trump administration may accelerate FDA tobacco approvals, fueling a 29% intraday rally as the company pushes the FDA to cap cigarette nicotine at 0.70 mg/g to curb youth initiation and reduce tobacco deaths.Previous Week RecapThis is…